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Although Yersinia enterocolitica is usually transmitted through contaminated food and untreated water, occasional transmission
such as human-to-human, animal-to-human and blood transfusion associated transmission have also identified in human disease.
Of the six Y. enterocolitica biotypes, the virulence of the pathogenic biotypes, namely, 1B and 2–5 is attributed to the presence
of a highly conserved 70-kb virulence plasmid, termed pYV/pCD and certain chromosomal genes. Some biotype 1A strains,
despite lacking virulence plasmid (pYV) and traditional chromosomal virulence genes, are isolated frequently from humans with
gastrointestinal diseases similar to that produced by isolates belonging known pathogenic biotypes. Y. enterocolitica pathogenic
biotypes have evolved two major properties: the ability to penetrate the intestinal wall, which is thought to be controlled by
plasmid genes, and the production of heat-stable enterotoxin, which is controlled by chromosomal genes.
1. Introduction
Yersinia enterocolitica was discovered more than 60 years
ago [1] but was not considered as a human or veterinary
pathogen until the late 1960s when it became increasingly
identified in foodborne gastrointestinal infections [2, 3].
Y. enterocolitica is a member of the genus Yersinia which
encompasses a heterogeneous collection of facultatively
anaerobic bacteria that belong to the family Enterobac-
teriaceae. Of the 11 species within this genus [4], only
three, Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica
are regarded as pathogenic for humans whereas Y. ruckeri
is a fish pathogen, and Y. enterocolitica-like organisms Y.
krirtensenii, Y. intermedia, Y. mollaretii, Y. frederiksenii and
Y. bercovieri have yet an unidentified role in human disease
[5]. Y. enterocolitica is associated with a wide range of clinical
and immunological manifestations, responsible for intestinal
diseases, including enterocolitis with an inflammatory diar-
rhea in aﬀected infants and young children; acute terminal
ileitis and mesenteric lymphadenitis mimicking appendicitis
in older children and young adults, as well as rare extrain-
testinal manifestations including urinary tract and respi-
ratory tract infection (empyema), osteoarticular infection
(reactive arthritis), erythema nodosum, infected mycotic
aneurysm [6–8], axillary abscesses [9], and endocarditis
[10].
The geographical distribution of Y. enterocolitica is
diverse. Y. enterocolitica has more than 50 distinct serotypes
(on the basis of antigenic variations in cell wall lipopolysac-
charide), and few of them are pathogenic. O:8 is the primary
infectious serotype in the USA followed by O:3, O:5, 27,
O:13a,13b, O:20, O:9, and so forth [6, 7]. In China, serotype
O:3 is primarily found in infections followed by O:9 and
O:8 [14]. Furthermore, various serotypes demonstrate geo-
graphical specificity; for example, the predominant serotype
in Australia, Europe, and Canada is O:3 [5], O:8 in Japan
[15], and O:9 in Scandinavia, the Netherlands [16].
The incidence of Y. enterocolitica foodborne infection
varies according to geography and climate variation. In
developed countries, the incidence is higher in infants and
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Figure 1: Mode of transmission of Y. enterocolitica.
young children, although all ages are at risk. The majority of
foodborne infections are sporadic, and the infection sources
are unknown, but large outbreaks have also occurred [5, 17,
18]. Y. enterocolitica foodborne outbreaks have occurred in
Australia, Finland, Japan, Norway, the United States, and
Brazil. There were two foodborne outbreaks in China in
1980s; one was caused by beef contamination in Lanzhou
of Gansu Province in 1986 with 109 patients with diarrhea
caused by Y. enterocolitica O:3 infection [19]. The second
occurred in a school in Shenyang of Liaoning Province
with 352 students having diarrhea caused by Y. enterocolitica
O:8 infection [14]. Recently, Y. enterocolitica has become
of concern worldwide, and foodborne infections have been
reported in hundreds of countries.
2. Mode of Transmission
2.1. Foodborne Transmission. Y. enterocolitica is an important
foodborne human enteropathogen that causes sporadic ill-
ness and occasional foodborne outbreaks in the United States
whereas incidence of yersiniosis and outbreaks appeared to
be higher in many European countries than the United States
[6, 20]. It has been isolated from many foods, including
beef, pork, liquid eggs, soft cheese, raw milk, pasteurized
milk, fish, raw oysters, shrimps, crabs, chocolate milk, turkey,
chow mein (chop suey served with fried noodles), powdered
milk, bean sprouts (especially mung beans, lentils, or edible
soybeans), and tofu (cheese-like food made of curdled
soybean milk). Although the organism has been isolated
from many foods, there have been relatively few foodborne
outbreaks attributed to Y. enterocolitica in developed coun-
tries, for example, Japan and the Netherlands [15, 16] as
well as in developing countries, for example, Bangladesh
and Iraq [21, 22]. Human yersiniosis is primarily acquired
through the gastrointestinal tract as a result of ingestion of
contaminated foods—usually raw or inadequately cooked
pork [16]. Y. enterocolitica foodborne outbreaks in the United
States have involved young children exposed indirectly
during the cleaning and preparation of raw or undercooked
pork chitterlings [23]. Chitterlings are generally well cooked,
so it is believed that hands, kitchen surfaces, or other kitchen
articles contaminated during the preparation of chitterlings
are the vehicles for foodborne infection. Survival of Yersinia
on these vehicles is facilitated by the hardiness of Yersinia,
which is able to multiply in adverse conditions like commer-
cial refrigeration temperatures. Other foodborne outbreaks
have been associated with untreated water, contaminated
tofu, contaminated bean sprouts, and contaminated milk
(unpasteurized or inadequately pasteurized milk) [20]. The
isolation of Yersinia strains from contaminated milk can
be probably the result of postpasteurization contamination,
since even the most heat-resistant strains are reported to be
killed by pasteurization (Figure 1).
2.2. Human-to-Human Transmission. Person-to-person
transmission is rare. However, contamination of food by
infected food handler and nosocomial infections have been
reported. In July 2006, person-to-person transmission
was observed in a familial outbreak of Y. enterocolitica
bioserotype 2/O:9 in Japan [24]. The possible source of
this infection was an infected carrier who suﬀered from
diarrhea [24]. In addition, the outbreak of diarrheal disease
due to Yersinia enterocolitica bioserotype 1/0:5 was reported
in hospitalized patients, which was the indication of a
nosocomial outbreak due to Yersinia enterocolitica [25].
2.3. Animal-to-Human Transmission and Waterborne Trans-
mission. Occasionally Y. enterocolitica infection occurs after
direct or indirect contact with infected animals. It has
been isolated from the intestinal tracts and feces of many
animals, including rodents (rabbits), domestic animals (e.g.,
sheep, cattle, cats, pigs, and dogs) [26], and other animals
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(deer, raccoons, and horses) and water contaminated by
those animals. The pig appears to be the main reservoir
for the strains causing infection in humans. Pig feces are a
potential mode of direct transmission to farmers [27]. As
Y. enterocolitica possess the ability to grow under extreme
environmental condition, they are welladapted to survival
in cooler temperate zones as well as in microaerophilic
environments including aquatic environments.
2.4. Direct Transmission. Y. enterocolitica rarely causes extra-
intestinal disease. In case of extraintestinal disease, direct
transmission is proposed as the mode of transmission of
this classically enteric pathogen [9]. In January 2009, a 54-
year-old African American construction worker with chronic
hepatitis C developed an axillary abscess due to Y. enteroco-
litica that followed an injury to his finger. It was proposed
that the finger pustule arising as a consequence of traumatic
puncture presented the possibility that direct inoculation
of Y. enterocolitica from an environmental source may have
been the mode of transmission. These suggest an alternative
nonfoodborne route for Y. enterocolitica transmission. A
similar route of transmission was proposed for a patient
with Y. enterocolitica axillary abscess whose employment as
a butcher subjected him to frequent cut wounds to the hand
[28].
2.5. Blood Transfusion-Associated Transmission. Yersinia en-
terocolitica can be transmitted through contaminated blood,
and it was one of the first recognized causes of posttrans-
fusion sepsis [29]. This first case of transfusion-associated
sepsis caused by Y. enterocolitica was described in the Nether-
lands in 1975. Since then, more than 60 additional cases have
been reported in the literature worldwide. Y. enterocolitica
has occurred occasionally in donor blood from healthy
donors or donors with a diarrhea history; such contaminated
blood sometimes caused Yersinia bacteremia and death of
the recipients [30]. Although fatality due to posttransfusion
bacterial-associated sepsis is rare [31], blood-transfusion-
associated septicemia due to Y. enterocolitica is reported to
have high fatality rate. In 2003, a fatal case of septic shock was
observed in a 71-year-old patient following transfusion of
contaminated red blood cells (RBCs) for refractory anemia.
Y. enterocolitica bioserotype 4/O:3 was isolated from the
patient’s blood sample and the transfused RBCs. High titers
of antibodies against Y. enterocolitica were detected in the
donor’s plasma sample one month after blood donation. The
donor reported abdominal discomfort 3.5 months before
blood collection but had no clinical signs of intestinal
infection at the time of donation [32].
3. Molecular Insights in Virulence
Yersinia enterocolitica has evolved into an apparently het-
erogeneous collection of organisms encompassing six bio-
types diﬀerentiated by physiochemical and biochemical
tests (1A, 1B, 2, 3, 4, and 5; Table 1) and more than 50
serotypes diﬀerentiated by antigenic variation in cell wall
lipopolysaccharide. Of the six biotypes, biotype 1A is the
most heterogeneous, and encompasses a wide range of
serotypes (Table 2), of which serotypes O:5, O:6,30, O:6,31,
O:7,8, O:10, as well as O-nontypable strains, are isolated
most often [33]. The virulence of the pathogenic biotypes,
namely, 1B and 2–5 is attributed to the presence of a highly
conserved 70-kb virulence plasmid, termed pYV/pCD and
certain chromosomal genes [42] (Table 3). The biotype 1A
strains of Y. enterocolitica, on the other hand, have been
reported to lack pYV plasmid which encodes virulence
factors including Yersinia adhesin A (YadA) and Ysc-Yop
type III secretion system (TTSS) as well as chromosomally
borne virulence genes including ail, myfA, ystA, ysa, and the
high pathogenicity island- (HPI-) associated iron acquisition
system [35] (Figure 2).
3.1. Virulence Factors of pYV-Bearing Strains of Y. enteroco-
litica [33]. Apart from pYV itself, pYV-bearing strains of
Y. enterocolitica require a number of chromosomally borne
genes to express full virulence. Some of these virulence genes
are restricted to pYV-bearing bacteria whereas others occur
more widely. Virulence genes that are mostly limited to
pYV-bearing strains of Y. enterocolitica include inv (encodes
invasin, an outer membrane protein that is required for
eﬃcient translocation of bacteria across the intestinal epithe-
lium) [43]); ail (encodes another outer membrane protein
that may contribute to adhesion, invasion, and resistance
to complement-mediated lysis) [44]; yst (encodes Yersinia
stable heat-stable enterotoxin that may contribute to the
pathogenesis of diarrhea associated with acute yersiniosis)
[45, 46]; myf (encodes a fimbrial antigen and putative
adhesin) [47]. In addition, strains of biotype 1B, which are
particularly virulent for humans and laboratory animals,
carry a high-pathogenicity island (HPI) which facilitates the
uptake and utilization of iron by bacterial cells, and hence
may promote their growth under iron-limiting conditions
in host tissues [48]. Virulence-associated determinants of
pYV-bearing Y. enterocolitica that also occur in pYV-negative
strains include cell surface lipopolysaccharide and SodA (a
superoxide dismutase), which appear to facilitate bacterial
survival in tissues [49, 50], as well as urease, which enhances
bacterial resistance to stomach acid and may also play a role
in nitrogen assimilation [51].
pYV functions mainly as an antihost plasmid that
permits the bacteria which carry it to resist to phagocytosis
and complement-mediated lysis, thus allowing them to
proliferate extracellularly in tissues. The pYV plasmid-
encoded virulence factors include an outer membrane pro-
tein adhesin, YadA, and a type III protein secretory apparatus
which translocates eﬀector proteins, known as Ysc-Yops,
from the bacterial cell to the cytoplasm of susceptible host
cells [42]. The contribution of pYV-encoded factors, in
particular YadA and the Yop eﬀectors, to bacterial virulence
has been established in a large number of studies. Strains
of Yersinia which lack pYV are susceptible to killing by
complement and polymorphonuclear leukocytes, although
they are able to persist in macrophages and nonprofessional
phagocytic cells, and cause short-lived infections which are
typically asymptomatic [52].
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Table 1: Biotyping scheme of Y. enterocolitica (adapted from [33, 34]).
Test
Reaction of biotype
1A 1B 2 3 4 5
Lipase (Tween hydrolysis) + + − − − −
Aesculin hydrolysis V − − − − −
Indole production + + (+) − − −
D-Xylose fermentation + + + + − v
Voges-Proskauer reaction + + + + + (+)
Trehalose fermentation + + + + + −
Nitrate reduction + + + + + −
Pyrazinamidase + − − − − −
B-D-Glucosidase + − − − − −
Proline peptidase v − − − − −
+, positive; (+), delayed positive; –, negative; v, variable reactions.
Table 2: Relationship between biotype, O serotype, and pYV carriage of Y. enterocolitica (adapted from Sharon et al. 2003).
Biotype Serotype(s)
1A O:4; O:5; O:6,30; O6,31; O:7,8; O:7,13; O:10; O:14; O:16; O:21; O:22; O:25; O:37; O:41,42; O:46; O:47; O:57; NTa
1B O:4,32b; O:8b; O:13a,13bb; O:16; O:18b; O:20b; O:21b; O:25; O:41,42; NT
2 O:5,27b; O:9b; O:27
3 O:1,2,3b; O:3b; O:5,27b
4 O:3b
5 O:2,3b
a
NT, not typable.
bSerotypes which include strains that carry pYV.
Table 3: Virulence-associated genes in Y. enterocolitica.
Genes Gene product/function Reference
InvC,tr
Invasin (an outer membrane protein that is required for eﬃcient translocation of bacteria across the
intestinal epithelium)
[35]
ailC,tr
Adhesin (outer membrane protein that may contribute to adhesion, invasion, and resistance to
complement-mediated lysis)
[36]
virFC,tr Transcriptional activator [36]
myfAC Mucoid Yersinia factor (fimbrial antigen and putative adhesin) [37]
ystAC,tr Enterotoxin (Yersinia stable heat-stable toxin that may contribute to the pathogenesis of diarrhea) [38]
ystBC Enterotoxin (Yersinia stable heat-stable toxin that may contribute to the pathogenesis of diarrhea) [38]
ystCC Enterotoxin (Yersinia stable heat-stable toxin that may contribute to the pathogenesis of diarrhea) [39]
fepA Enterochelin receptor protein [40]
fedD Enterochelin receptor protein [40]
Fes Enterochelin esterase [40]
tccCP Insecticidal toxin-like protease [35]
ymoA Yersinia modulator [41]
hreP Subtilisin/kexin-like protease (host responsive element) [35]
Sat Streptogramin acetyltranferase [35]
yadAP,tr Yersinia adhesin A [42]
ysaP Yesinia secretion apparatus [42]
CChromosome borne gene, Pplasmid-borne gene, tr traditional virulence gene.
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Figure 2: Y. enterocolitica biotypes. Y. enterocolitica biotypes are classified into three distinct group: a historically defined nonpathogenic
group (biogroup 1A); a weakly pathogenic group that are unable to kill mice (biogroups 2 to 5); a highly pathogenic, mouse-lethal group
(biogroup 1B). Biotype 1A strains are clustered into two clonal groups (A and B) when typed by repetitive extragenic palindrome (REP)—
and enterobacterial repetitive intergenic consensus (ERIC)—PCR fingerprinting [11], and two groups when typed by fluorescent amplified
fragment length polymorphism (FAFLP) [12].
3.2. Evidence Indicating the Lack of Virulence of Biotype
1A Strains. Biotype 1A strains of Y. enterocolitica are often
considered to be nonpathogenic primarily because they do
not possess the virulence-associated factors of pYV-bearing
strains. The biotype 1A strains have been reported to lack
both pYV plasmid and most chromosomal virulence genes
such as ail, myfA, ystA, ysa, TTSS, and HPI, and only
occasionally carry ystA and myfA [53]. Although the ail
gene is present in some biotype 1A strains, the ail gene
alone is an insuﬃcient virulence marker for detecting the
virulence of Y. enterocolitica biotype 1A strains [54]. Another
line of evidence that is taken to indicate the avirulence of
biotype 1A strains is their relatively high prevalence in the
environment and healthy animals. Indeed, biotype 1A strains
are ubiquitous, inhabiting a wide variety of environmental
niches such as soil and various sources of water, including
streams, lakes, water wells, and wastewater [55, 56] Sharon
et al. 2003. They are also frequently isolated from foods,
including various vegetables and animal products, such
as pork, poultry, packaged meat, seafood, raw milk, and
pasteurized dairy products. Biotype1A are also found in a
vast array of animals, including birds, fish, various insects,
frogs, and a wide range of mammals, including cattle, sheep,
pigs, and rodents. In most cases, animals infected with
biotype 1A strains are asymptomatic, thus giving support to
the concept that these bacteria are avirulent commensals [33]
(Table 4).
3.3. Some Studies Indicating the Pathogenicity in Some Y.
enterocolitica Biotype 1A Strains. Despite the lack of tra-
ditional chromosomal-borne and plasmid-borne virulence
genes in Y. enterocolitica strains of biotype 1A, some bio-
type 1A strains are isolated frequently from humans with
gastrointestinal diseases. The biotype 1A strains isolated
from humans and from pigs have been reported to produce
ystB-encoding Yersinia heat-stable enterotoxin [53]. A recent
study on 259 isolates of Y. enterocolitica and related species;
indicated that Yst-B (ystB) was the major contributor to
diarrhea produced by biotype 1A strains of Y. enteroco-
litica [62]. Some biotype 1A strains produce symptoms
indistinguishable from that produced by isolates belonging
to pathogenic biotypes [63, 64]. Biotype 1A strains have
also been implicated in nosocomial [25] and foodborne
[65] outbreaks, and were also isolated from extraintestinal
infections [66].
4. Pathogenesis
Yersinia enterocolitica pathogenesis is incompletely under-
stood. Most isolates of Y. enterocolitica from food or clinical
materials have either of two pathogenic properties. First
property is the ability to penetrate the intestinal wall, which
is thought to be controlled by 70-kb virulence plasmid
(pYV/pCD) genes; that is absent in avirulent strains; second
one is the production of heat-stable enterotoxin which is
controlled by chromosomal genes (ystA, ystB, and ystC) [61].
4.1. Adaptation. As contaminated foods are considered as
the common mode of transmission, this microorganism
must first adapt its surface antigenic structures like outer
membrane proteins to colonize in the intestines of humans
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Table 4: Studies indicating the lack of virulence of biotype 1A strains.
Research studies References
(1) Two large studies in Belgium, involving the microbiological investigation of more than 24,000 fecal samples
over a period of almost 16 years, revealed that infection with biotype 1A was not associated with gastrointestinal
symptoms and that biotype 1A strains were more frequent amongst subjects having no gastrointestinal
complaints.
Van Noyen et al.
[57, 58]
(2) Rabbits were infected perorally with diﬀerent biotype 1A strains from raw fish (serotype O:6,30) and pig
intestine (serotype O:5), respectively, and concluded that these bacteria were avirulent.
Pai et al. [59]Une [60]
(3) Robins-Browne et al. reported that gnotobiotic piglets, inoculated perorally with a biotype 1A strain of
serotype O:5, which was originally isolated from milk, rapidly cleared the bacteria without developing any clinical
or pathological evidence of disease.
Robins-Browne et al.
[61]
at a temperature of about 37◦C. This is usually achieved in
part through the presence of 70-kb virulence plasmid (pYV).
Genes on this plasmid encode for several outer membrane
proteins (polypeptides) that are expressed at 37◦C but not at
25◦C [6].
4.2. Adhesion. Attachment of pYV-bearing strains (path-
ogenic biotypes 1B and 2–5) of Y. enterocolitica to tissue
culture cells like HeLa cells or HEp-2 cells cultures has
been frequently identified in pathogenic Yersinia isolates
[5, 67, 68]. However, the ability to produce disease does
not correlate with HeLa cell attachment as plasmid cured
avirulent strains retain the ability to attach to HeLa cells
[69]. When the pYV plasmid-containing strain was grown
at 26◦C in calcium-containing medium, the bacteria adhered
to HeLa cells and HEp-2 cell cultures to a high degree.
In contrast, when this strain was incubated at 37◦C in the
same calcium-containing medium, it attached to the HeLa
cells and HEp-2 cell cultures at a reduced level [70]. By
insertional inactivation of genes located on the virulence
plasmid (pYV), Kapperud et al. [71] identified four plasmid-
dependent and temperature-inducible properties related to
the bacterial surface properties involved in fimbrial adhesion:
(i) a fimbrial matrix covering the outer membrane, (ii) outer
membrane protein, YOP1 which is a structural component
of the fimbriae, (iii) spontaneous autoagglutination, which
is related to the fimbriae, and (iv) mannose-resistant hemag-
glutination of guinea pig erythrocytes [71].
Although the biotype 1A strains of Y. enterocolitica have
been reported to lack pYV plasmid, various forms of fimbriae
are observed in this biotype. One of fimbriae, designated
MR/Y-HA is 8 nm in diameter, agglutinates erythrocytes
of 10 diﬀerent animal species in the presence of mannose
and is expressed in vitro at low temperature, but not at
37◦C [72]. A second type of fimbriae, designated MR/K-
like HA, is 4 nm in diameter and mediates mannose-
resistant hemagglutination of chicken erythrocytes, but not
erythrocytes from a variety of other species [72]. Expression
of these fimbriae in vitro occurs only after serial passages of
bacteria for at least 7 days. Moreover, as they do not mediate
adherence of bacteria to cultured epithelial cells [73], their
contribution to the pathogenesis of infection with biotype
1A strains is unknown [33].
Some strains of Y. enterocolitica produce a fimbrial
adhesin, named Myf (for mucoid Yersinia fibrillae), because
β1 integrin
Invasin
Yersinia
Epithelial cell
Figure 3: A paradigm of “zippering” entry of a bacterial pathogen
into epithelial cells. Invasin mediated binding of Yersinia to β1
integrins and internalization (adapted from [13]).
it bestows a mucoid appearance on bacterial colonies which
express it. Myf are narrow flexible fimbriae which resemble
CS3, an essential colonization factor of some human clinical
strains of enterotoxigenic Escherichia coli [33]. However, myf
genes-associated virulence of these bacteria is unknown.
4.3. Invasiveness (Mechanisms of Epithelial Cell Invasion).
Entry of enteroinvasive bacteria into the intestinal epithelial
cell is the key to a successful invasive process. The ability of
Y. enterocolitica to invade epithelial cells is an important cor-
relation of pathogenicity [8]. The invasive process includes
a major signalling process that an invasive microorganism
may provoke to force its way into a nonphagocytic cell, and
then disrupting and invading the intestinal barrier, a process
that involves interaction with other cellular components of
this barrier. There are essentially two major mechanisms of
bacterial epithelial cell internalization [74] The “zippering”
process corresponds to tight enclosing of the bacterial cell
by the mammalian cell membrane, involving a surface
bound bacterial protein binding an adherence molecule of
the mammalian cell surface with high aﬃnity—that is, the
invasin (Inv) of Yersinia binding integrins of the β1 family
of mammalian cell surface [75]. One reason that strains of
biotype 1A have been considered to be avirulent is that they
invade tissue culture cells to a lesser extent than pYV-bearing
strains [69, 76]. However, paradoxically, some pYV-bearing
strains themselves may retard mammalian epithelial cell
invasion via the eﬀects of translocated Yops on cytoskeletal
proteins [42] as well as some biotype 1A strains are positive
for the ail gene encoded an outer membrane protein that
may contribute to epithelial cell adhesion and invasion [77]
(Figure 3).
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Figure 4: Physiopathological scheme of Yersinia infection. The Yops are delivered into the host cells via a type III secretion system. YopH,
a tyrosine phosphatase, dephosphorylates Cas and FAK (protein tyrosine kinase) in epithelial cells, and Cas, Fyb, and SKAP-HOM in
macrophages that are involved in the assembly of cytoskeletal complexes required for phagocytosis [78]; YopT modifies the Rho family
GTPases by inducing redistribution of the RhoA GTPase [79]; YopE inactivates the Rho family of GTPases involved in phagocytosis [80];
YpkA binds to Rac and Rho (function unknown). These four Yops alter or disrupt the actin cytoskeleton and thereby block phagocytosis.
YopJ impairs activation of MAPKKs and NF-B, which induces apoptosis and inhibits cytokine production. YopM is translocated into the
nucleus (function unknown; adapted from [13]).
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4.4. Local and Systemic Dissemination. Y. enterocolitica usu-
ally causes a diarrheal disease, and sometimes systemic diﬀu-
sion. Yersinia virulent strains cross the intestinal epithelium
primarily through the FAE (follicle associated epithelial cell),
in the Peyer’s patches of the ileum [81]. Invasin (Inv), a
103 kDa outer membrane protein of Yersinia binds β1 inte-
grins that are also expressed apically on M cells. Inv negative
mutants still adhere to and invade M cells, but at a much
lower level than the wildtype strain and their colonization
potential for Peyer’s patches is considerably reduced [82].
Other Yersinia surface proteins such as Ail, PsaA, and YadA
may account for residual invasion of inv mutants [83].
After invasion process, Yersinia defend the attack by resident
macrophages by expressing an antiphagocytic strategy medi-
ated by a plasmid encoded type III secretion, of three protein
eﬀectors, YopH, T, and E, that disrupt cytoskeletal assembly
required for phagocytosis process [84, 85]. Yersinia strains
therefore remain extracellular in infected Peyer’s patches and
mesenteric lymph nodes, and then disseminate to cause local
and systemic infection (Figure 4).
5. Conclusion
Yersinia enterocolitica is most often transmitted by con-
sumption of contaminated food (most commonly raw or
undercooked pork), unpasteurized milk or inadequately
pasteurized milk, untreated water, or by direct or indirect
contact with animals. The virulence of Y. enterocolitica
strains mostly depends on the presence of pYV plasmid. Y.
enterocolitica pYV-positive strains contain plasmid-mediated
virulence genes involved in developing infection especially in
gastrointestinal tract with the help of traditional chromoso-
mal genes whereas pYV-negative strains are mostly noninfec-
tious except heat-stable enterotoxin-producing strain.
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